Please login to the form below

Not currently logged in
Email:
Password:

hVIVO

This page shows the latest hVIVO news and features for those working in and with pharma, biotech and healthcare.

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

UK BIOTECH. Universal flu vaccine shows promise in phase 2. UK next-generation vaccines company hVIVO has unveiled promising results for its universal flu vaccine candidate. ... FLU-v is being developed by Imutex, hVIVO's 49% joint venture with PepTcell

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics